Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Satellos Bioscience Inc. MSCLF

Full chart Compare

Set alert

6.25 USD 0.00 (+0.00%)

Apr 8, 2026, 9:30 AM EDT

5.77 Day range 6.39

0.88 52-week range 12.50

YTD: +6.29%
1 year: -5.16%

News

8 hours ago globenewswire.com Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage biotechnology company developing potentially life-improving medicines to treat…